- Home
- THRM vs ABSI Comparison
THRM vs ABSI Comparison
Compare THRM & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | THRM | ABSI |
|---|---|---|
| Founded | 1991 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.4B |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | THRM | ABSI |
|---|---|---|
| Price | $31.82 | $10.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $48.00 | $14.90 |
| AVG Volume (30 Days) | 2.3M | ★ 3.5M |
| Earning Date | 10-22-2026 | 11-12-2026 |
| Dividend Yield | ★ 7.24% | N/A |
| EPS Growth | N/A | ★ 10.64 |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $554,979,000.00 | $4,534,000.00 |
| Revenue This Year | $15.24 | $39.03 |
| Revenue Next Year | $43.30 | $310.91 |
| P/E Ratio | $151.11 | ★ N/A |
| Revenue Growth | ★ 50.16 | N/A |
| 52 Week Low | $25.31 | $2.24 |
| 52 Week High | $48.35 | $12.06 |
Technical Indicators
Market Signals| Indicator | THRM | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 49.19 | 59.24 |
| Support Level | $28.44 | $8.15 |
| Resistance Level | $32.11 | $11.73 |
| Average True Range (ATR) | 1.79 | 0.82 |
| MACD | 0.29 | 0.08 |
| Stochastic Oscillator | 87.65 | 99.28 |
Price Performance
Historical ComparisonAbout THRM Gentherm Inc
Gentherm Inc is an automotive parts manufacturer. The business activities of the group function through the Automotive and Medical segments. The vast majority of the firm's revenue comes from the Automotive segment, which includes automotive climate comfort systems, automotive cable systems, battery performance solutions, and automotive electronics and software systems. The medical segment is comprised of the results from the patient temperature management business in the medical industry. Its geographical segments are the USA, China, South Korea, Germany, Japan, the Czech Republic, and other countries.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.